A look back at some of the top stories on Specialty Pharmacy Times from March 16-20.
Nanoparticles May Increase Effectiveness of Lung Cancer Drugs
Treatment can selectively drop medication at the site of tumors.
http://www.specialtypharmacytimes.com/news/Nanoparticles-May-Increase-Effectiveness-of-Lung-Cancer-Drugs
New Approach Needed to Finance Expensive Specialty Drugs
Report finds suppliers could spur investment through methods that include equipment leases or supplier-financed credit.
http://www.specialtypharmacytimes.com/news/New-Approach-Needed-to-Finance-Expensive-Specialty-Drugs
FDA Accepts Combination Hepatitis C Treatment Application for Review
Bristol-Myers Squibb is also clinically testing the potential of daclatasvir-based regimens in patients co-infected with HIV.
http://www.specialtypharmacytimes.com/news/FDA-Accepts-Combination-Hepatitis-C-Treatment-Application-for-Review
Preventing Early Menopause in Breast Cancer Patients
Risk of sudden onset menopause reduced by adding goserelin to chemotherapy regimen.
http://www.specialtypharmacytimes.com/news/Preventing-Early-Menopause-in-Breast-Cancer-Patients
FDA Approves Treatment for Bile Acid Synthesis Disorders
First treatment option approved for rare condition.
http://www.specialtypharmacytimes.com/news/FDA-Approves-Treatment-for-Bile-Acid-Synthesis-Disorders
Improper Temperature Control: A Global Problem
Globally, from Tunisia to the United States, underuse of digital temperature loggers leads to loss of product potency and efficacy for patients.
http://www.specialtypharmacytimes.com/news/Improper-Temperature-Control-A-Global-Problem
Gene Therapy Could Generate Powerful Hemophilia Treatment
Process produces protein with high blood clotting ability.
http://www.specialtypharmacytimes.com/news/Gene-Therapy-Could-Generate-Powerful-Hemophilia-Treatment
Herpes Drug May Lower HIV Levels
Study finds HIV-1 viral loads decreased following treatment with Valtrex.
http://www.specialtypharmacytimes.com/news/Herpes-Drug-May-Lower-HIV-Levels
Antibody Therapy Shows Promise in Halting Psoriasis
Experimental treatment blocks signaling protein.
http://www.specialtypharmacytimes.com/news/Antibody-Therapy-Shows-Promise-in-Halting-Psoriasis
Antisense Technology Shows Promising Results in Crohn’s Disease Treatment
Significant number of patients taking once daily oral therapy achieve clinical remission during a recent trial.
http://www.specialtypharmacytimes.com/news/Antisense-Technology-Shows-Promising-Results-in-Crohns-Disease-Treatment
In Case You Missed It: Specialty Pharmacy Times Week in Review
2015-03-22 10:59:00
Davy James, Managing Editor